Gene Synthesis (Research-use) Market Size and Share Analysis - Growth Trends and Forecasts (2026-2033)

Market Size and Trends

The Gene Synthesis (Research-use) market is estimated to be valued at USD 1.6 billion in 2026 and is expected to reach USD 3.4 billion by 2033, growing at a compound annual growth rate (CAGR) of 11.5% from 2026 to 2033. This significant growth reflects the increasing demand for synthetic genes in various research applications, including drug discovery, synthetic biology, and genetic engineering, driven by advancements in technology and expanded adoption in academic and commercial research laboratories worldwide.

Current market trends indicate a robust shift towards automation and integration of AI-driven tools in gene synthesis processes, enhancing accuracy and reducing turnaround time. Additionally, there is a growing emphasis on custom gene synthesis services tailored to specific research needs, alongside expanding applications in therapeutics and personalized medicine. The rise in collaborative research projects and government funding for genetic research further propels innovation and market expansion, positioning this sector for sustained growth in the coming years.

Segmental Analysis:

By Product Type: Oligonucleotides Drive Precision and Versatility in Gene Synthesis

In terms of By Product Type, Oligonucleotides contribute the highest share of the Gene Synthesis (Research-use) market owing to their fundamental role as building blocks in genetic research and molecular biology applications. Oligonucleotides are short DNA or RNA sequences synthesized with high precision, enabling researchers to study gene functions, develop probes, primers, and serve as essential components in PCR amplification and sequencing technologies. Their wide applicability across multiple research domains makes them indispensable. The demand for customized oligonucleotides with enhanced accuracy and modifications propels this segment, as researchers seek tailored solutions for applications ranging from gene editing to diagnostic assays. Additionally, advancements in synthesis technologies have reduced turnaround times and improved yield and purity, thereby reinforcing the preference for oligonucleotides in experimental workflows. The ability to rapidly design and produce specific sequences facilitates innovation in gene expression studies and therapeutic development, further solidifying this segment's dominance. Its compatibility with high-throughput platforms and growing use in emerging fields such as CRISPR technologies and next-generation sequencing continues to drive consistent demand and investment, highlighting oligonucleotides as a critical segment in gene synthesis research tools.

By Application: Synthetic Biology Spurs Broad Adoption of Gene Synthesis

In terms of By Application, Synthetic Biology contributes the highest share of the Gene Synthesis (Research-use) market, reflecting its transformative role in reshaping biological engineering and innovation. Synthetic biology involves the design and construction of new biological parts, devices, and systems or the redesign of existing natural biological systems for useful purposes. This field's rapid expansion is fueled by the increasing ability to precisely synthesize and assemble genetic material, enabling scientists to engineer microorganisms for biofuel production, environmental remediation, and biosensors. Gene synthesis technologies provide the foundation for creating synthetic pathways, metabolic circuits, and even entirely synthetic genomes, empowering researchers to manipulate biological functions with unprecedented control. The convergence of synthetic biology with automation, computational modeling, and high-throughput synthesis accelerates research cycles and broadens applications, which in turn escalates demand for reliable gene synthesis products. Furthermore, the rise of personalized medicine and development of synthetic biomolecules for therapeutic applications increases reliance on synthetic biology approaches. As the sector expands beyond academic research into industrial biotechnology and pharmaceuticals, gene synthesis continues to be a critical enabling tool, driving the dominance of synthetic biology as the leading application segment.

By End-User: Pharmaceutical & Biotechnology Companies Lead Innovation and Investment in Gene Synthesis

In terms of By End-User, Pharmaceutical & Biotechnology Companies hold the largest share of the Gene Synthesis (Research-use) market due to their central role in drug discovery, development, and personalized medicine. These companies harness gene synthesis technologies to construct DNA sequences that enable the design of novel therapeutics, including biologics, gene therapies, and vaccines. The ability to rapidly synthesize specific genes accelerates target identification, validation, and screening processes, thereby shortening drug development timelines and reducing costs. Pharmaceutical and biotech firms are increasingly investing in advanced synthetic biology platforms and high-throughput gene synthesis to enhance pipeline productivity and innovation capacity. The augmented focus on precision medicine, particularly in oncology and rare genetic disorders, further stimulates demand for custom genetic sequences tailored to patient-specific profiles. Additionally, these companies often collaborate with contract research organizations and academic institutions, fostering an integrated ecosystem that relies heavily on reliable, scalable gene synthesis services. With robust funding, regulatory focus on genetic therapies, and expanding applications, pharmaceutical and biotechnology companies remain the most influential end-users driving growth and adoption in the gene synthesis research market.

Regional Insights:

Dominating Region: North America

In North America, the gene synthesis market (research-use) holds a dominant position driven by a well-established market ecosystem and strong infrastructure supporting biotechnology research. The presence of numerous leading academic institutions and research centers fuel continuous demand for gene synthesis technologies. Robust government funding and favorable policies aimed at advancing genetic research and innovation contribute significantly to market leadership. Moreover, the thriving biotechnology and pharmaceutical industries within the US and Canada create an ecosystem conducive to the adoption of advanced gene synthesis solutions. Key players such as Thermo Fisher Scientific, Integrated DNA Technologies (IDT), and Ginkgo Bioworks have their headquarters or major operations here, driving innovation and accessibility in gene synthesis products. The mature trade framework and intellectual property protections further solidify North America's dominance in this market.

Fastest-Growing Region: Asia Pacific

Meanwhile, the Asia Pacific region exhibits the fastest growth trajectory in the gene synthesis market for research use. This accelerated expansion is supported by rising investments in biotechnology and life sciences, expanding research infrastructure, and increasing government initiatives to promote biotechnological innovation. Countries such as China, India, South Korea, and Japan are aggressively investing in synthetic biology research, enhancing domestic capabilities in gene synthesis technology. The growing number of startups and emerging biotech enterprises alongside multinational companies establishing regional hubs contribute to vibrant market growth. Government policies facilitating foreign direct investment, coupled with improving regulatory frameworks, help fuel this rapid expansion. Companies like BGI Genomics (China), GenScript (China), and Cosmo Bio (Japan) are particularly influential in driving regional market growth by offering advanced gene synthesis tools tailored to local research demands.

Gene Synthesis (Research-use) Market Outlook for Key Countries

United States

The United States' gene synthesis market benefits from a sophisticated biotechnology sector marked by cutting-edge research and development activities. The US government's supportive funding environment, through bodies like NIH and NSF, boosts various genetic and genomic initiatives requiring reliable gene synthesis solutions. Leading companies such as Thermo Fisher Scientific, with its renowned gene synthesis platforms, and Twist Bioscience, known for high-throughput synthetic DNA production, have significant impacts on the market. The concentration of biotech hubs across California, Massachusetts, and other regions ensures continuous innovation and broad adoption of gene synthesis technologies.

China

China's gene synthesis market is rapidly evolving, spurred by substantial governmental initiatives to establish the country as a global biotechnology leader. The Made in China 2025 strategy and related policies emphasize advancements in synthetic biology, thus encouraging gene synthesis market growth. Domestic companies like BGI Genomics lead in the synthesis of complex gene sequences, supported by expanding research institutions and collaborations with international firms. The supportive regulatory environment and strategic public-private partnerships enhance China's capabilities, facilitating the development of next-generation gene synthesis technologies.

Germany

Germany continues to lead Europe's gene synthesis market, benefiting from a robust industrial biotechnology sector and strong government support for genetic research initiatives. The German government's focus on innovation through research grants and favorable tax policies creates an enabling environment for companies and research institutions. Industry giants such as Eurofins Genomics and CEGAT (Center for Genomics and Transcriptomics) contribute significantly to the market by supplying customized gene synthesis services and advanced synthetic biology tools. Germany's strategic location within the European Union also strengthens trade and collaboration, boosting market stability and growth.

Japan

Japan's gene synthesis market exhibits steady advancement supported by a well-established pharmaceutical and biotechnology ecosystem. Government programs aimed at accelerating regenerative medicine and precision medicine research drive demand for sophisticated gene synthesis technologies. Companies like Cosmo Bio and Takara Bio have a pronounced presence in providing research-focused synthetic biology products and services. Japan's focus on innovation is further accelerated by collaborative efforts between industry and academia, alongside increasing investments in life sciences infrastructure, positioning it as a significant player in the Asia Pacific region.

India

India's gene synthesis market is marked by rapid growth, largely attributed to expanding academic research and government initiatives aimed at supporting biotechnology entrepreneurship. The Make in India campaign and increasing funding for life sciences research create a fertile environment for market growth. Indian companies such as Genei and Eurofins Genomics India cater to the growing research community by offering cost-effective and reliable gene synthesis services. The country's large pool of scientific talent and increasing international collaborations further contribute to the dynamism of India's gene synthesis market.

Market Report Scope

Market Segmentation

Product Type Insights (Revenue, USD, 2021 - 2033)

• Oligonucleotides
• Synthetic Genes
• Gene Fragments
• Custom DNA Libraries
• Others

Application Insights (Revenue, USD, 2021 - 2033)

• Synthetic Biology
• Drug Discovery & Development
• Agricultural Biotechnology
• Vaccine Development
• Others

End-user Insights (Revenue, USD, 2021 - 2033)

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Agricultural Companies
• Others

Regional Insights (Revenue, USD, 2021 - 2033)

• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa

Key Players Insights

• GenScript Biotech Corporation
• Twist Bioscience Corporation
• Integrated DNA Technologies (IDT)
• Eurofins Genomics
• Thermo Fisher Scientific
• Synbio Technologies
• GeneArt (a part of Thermo Fisher)
• BGI Genomics
• Agilent Technologies
• Biomatik
• DNA2.0
• Bio Basic Inc.
• Codex DNA
• BaseClear B.V.
• Sangon Biotech Co. Ltd.
• Takara Bio Inc.
• Evonetix